Wang Xie X - OmicsDI

Show results for

Unknown (11618)
Proteomics (255)
Transcriptomics (58)
Genomics (53)
Metabolomics (42)

Organisms

Homo sapiens (122)
Mus musculus (56)
Arabidopsis thaliana (4)
Ovis aries (3)
Rattus norvegicus (3)
Oryza sativa Japonica Group (2)
Sus scrofa (2)
Drosophila melanogaster (2)
Capra hircus (2)
Oryza sativa (2)
Escherichia coli (2)
Oryctolagus cuniculus (2)
Saccharomyces cerevisiae (2)
Larimichthys crocea (1)
Rhodococcus opacus (1)
Vitis labrusca x Vitis vinifera (1)
Taenia multiceps (1)
Tomato yellow leaf curl China virus (1)
Metarhizium acridum (1)
Bemisia tabaci (1)
Mytilus edulis (1)
Dirofilaria immitis (1)
Macaca mulatta (1)
Clonorchis sinensis (1)
Oryza sativa Indica Group (1)
Zea mays (1)
Solanum tuberosum (1)
Setaria italica (1)
Caenorhabditis elegans (1)
Gallus gallus (1)

Repository

pride (142)
iProX (111)
biostudies-arrayexpress (73)
MetaboLights (42)
EGA (38)
MassIVE (2)

Tissue

Cell culture (42)
Testis (13)
Brain (12)
Liver (12)
Epithelial cell (11)
Hepatocyte (6)
Kidney (5)
Lung (5)
Spleen (5)
Blood plasma (4)
Heart (4)
Blood cell (3)
Blood serum (3)
Bone marrow (3)
Breast (3)
Embryonic stem cell (3)
Leaf (3)
Permanent cell line cell (3)
Smooth muscle cell (3)
Breast cancer cell line (2)
Cell suspension culture (2)
Cerebrospinal fluid (2)
Embryo (2)
Fibroblast (2)
Gastric adenocarcinoma cell (2)
Malignant cell (2)
Neutrophil (2)
Plant cell (2)
Skin (2)
Whole body (2)

Disease

Breast cancer (4)
Disease free (4)
Hepatocellular carcinoma (3)
Cervix carcinoma (2)
Cholangiocarcinoma (2)
Colon cancer (2)
Liver cancer (2)
Prostate adenocarcinoma (2)
Type 2 diabetes mellitus (2)
Acute leukemia (1)
Alzheimer's disease (1)
Brain cancer (1)
Brain glioblastoma multiforme (1)
COVID-19 (1)
Carcinoma (1)
Dermatofibrosarcoma protuberans (1)
Esophageal carcinoma (1)
Gastric adenocarcinoma (1)
Head and neck squamous cell carcinoma (1)
Hemorrhagic stroke (1)
Human immunodeficiency virus infectious disease (1)
Ischemic stroke (1)
Osteoporosis (1)
Residual chronic schizophrenia (1)
Severe acute respiratory syndrome (1)
Stroke (1)
Thyroid cancer (1)

Technology Type

Mass Spectrometry (142)
Shotgun proteomics (74)
Mass spectrometry (38)
Bottom-up proteomics (24)
Affinity purification coupled with mass spectrometry proteomics (13)
Gel-based experiment (10)
Data-dependent acquisition (8)
Top-down proteomics (7)
Mass spectrometry assay (4)
All-ion fragmentation (4)
Data-independent acquisition (4)
SRM/MRM (4)
SWATH MS (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Affinity proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
DiaPASEF (1)
Mass spectrometry imaging (1)
Olink affinity proteomics (1)
Proteogenomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (21)
Liquid Chromatography MS - negative - reverse phase (20)
Liquid Chromatography MS - negative - hilic (5)
Liquid Chromatography MS - positive - hilic (5)
Illumina HiSeq 2500 (3)
Illumina NovaSeq 6000 (2)
Illumina HiSeq 2000 (2)
6540 Q-TOF LC/MS (Agilent) (2)
Liquid Chromatography MS - (2)
Liquid Chromatography MS - alternating - reverse phase (2)
BD FACSAria™ III (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)
Liquid Chromatography MS - alternating – hilic (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Xevo QTof MS (Waters) (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reversed-phase-chromatography (1)
Xevo G2 QTOF (Waters) (1)
Liquid Chromatography MS - positive - reverse-phase (1)

Publication Date

2024 (46)
2022 (43)
2025 (42)
2023 (30)
2021 (27)
2026 (22)
2019 (16)
2014 (14)
2012 (12)
2009 (12)
2020 (11)
2016 (9)
2018 (9)
2013 (8)
2015 (7)
2010 (6)
2011 (5)
2017 (4)
2006 (1)

CHEBI ID

CHEBI:17368 (17)
CHEBI:16704 (16)
CHEBI:16750 (16)
CHEBI:17154 (15)
CHEBI:17568 (15)
CHEBI:17596 (15)
CHEBI:16040 (14)
CHEBI:17895 (14)
CHEBI:17203 (13)
CHEBI:16467 (13)
CHEBI:48131 (13)
CHEBI:16359 (13)
CHEBI:16235 (13)
CHEBI:16027 (13)
CHEBI:16708 (13)
CHEBI:30769 (13)
CHEBI:17750 (12)
CHEBI:15971 (12)
CHEBI:18050 (12)
CHEBI:16015 (12)
CHEBI:17509 (12)
CHEBI:16737 (12)
CHEBI:16919 (12)
CHEBI:15354 (12)
CHEBI:17295 (12)
CHEBI:16857 (11)
CHEBI:27823 (11)
CHEBI:17562 (11)
CHEBI:16393 (11)
CHEBI:16411 (11)

Metabolite Name

Guanosine (12)
Hypoxanthine (12)
Guanine (10)
L-Proline (9)
Uracil (9)
Inosine (9)
Choline (8)
Adenosine (8)
Cytosine (8)
Azelaic acid (8)
Xanthine (8)
Uridine (8)
L-Tyrosine (8)
L-Phenylalanine (8)
Betaine (7)
L-Arginine (7)
Nicotinamide (7)
Cholic acid (7)
Adenine (7)
Cytidine (7)
Creatinine (7)
Creatine (7)
Propionylcarnitine (6)
Allantoin (6)
Pantothenic acid (6)
Taurine (6)
Spermidine (6)
Riboflavin (6)
Palmitic acid (6)
L-Tryptophan (6)

Modification

15.994915 (1)
2x(15)N labeled L-lysine (1)
4x(15)N labeled L-arginine (1)
57.021464 (1)
Not available (1)

Study type

Transcription profiling by array (28)
RNA-seq of coding RNA (18)
Methylation profiling by high throughput sequencing (10)
RNA-seq of non coding RNA (7)
ChIP-seq (5)
Unknown experiment type (1)
Animal - High-throughput sequencing (1)
Cell line - High-throughput sequencing (1)
Transcription profiling by RT-PCR (1)
RNA-seq of total RNA (1)

Release Date

2025 (2014)
2022 (1607)
2023 (1548)
2024 (1513)
2021 (1231)
2020 (859)
2019 (610)
2018 (498)
2017 (414)
2016 (331)
2026 (302)
2015 (272)
2014 (188)
2013 (104)
2012 (72)
2011 (49)
2009 (28)
2010 (26)
2008 (8)
2007 (6)
2005 (3)
2004 (3)
2006 (2)
2001 (2)
2003 (1)

Lab affiliation

Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Nanjing Medical University, Nanjing, Jiangsu, China (3)
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill,NC 27599,USA (2)
Huazhong University of Science and Technology (2)
Institute of Biophysics, Chinese Academy of Sciences (2)
Key Laboratory of Protein and Peptide Pharmaceuticals & Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China (2)
School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China (2)
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, Guangdong, P.R. China. (2)
Shanghai Center for Systems Biomedicine Shanghai Jiao Tong University (2)
St Jude Children's Research Hospital (2)
St. Jude Children's Research Hospital (2)
State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, China. (2)
State Key Laboratory of Reproductive Medicine and Offspring Health， Nanjing Medical University, Nanjing, China. (2)
State Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing 211166, Jiangsu, China (2)
Xiamen University (2)
westlake.edu.cn (2)
, Dana-Farber Cancer Institute, Harvard Medical School 360 Longwood Avenue Longwood Center, LC4117 Boston, MA 02215 (1)
1 Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, Zhejiang Province, China. 2 Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China. 3 Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China. (1)
1 Key Laboratory of Protein and Peptide Pharmaceuticals & Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China 2 University of Chinese Academy of Sciences, Beijing 100049, China (1)
1Department of Hematology, Xiangya Hospital, Central South University, Changsha 410080, China 2NHC Key Laboratory of Carcinogenesis, Department of Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China (1)
1Department of Pathology, Dana-Farber/Harvard Cancer Center, PhD Program in Immunology, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA (1)
1Department of Urology, Emory University School of Medicine, Atlanta, GA, USA (1)
Anhui Science and Technology University (1)
Associate Member Developmental Neurobiology St. Jude Children's Research Hospital (1)
BGI-Shenzhen (1)
Beijing Institute of Genomics, Chinese Academy of Sciences (1)
Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China (1)
CAS Key Laboratory of Genomics and Precision Medicine, Beijing Institute of Genomics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, China (1)
Center for Genomics Department of Basic Sciences Loma Linda University School of Medicine (1)
Center for Infectious Diseases Research Department of Pathology and Genomic Medicine Houston Methodist Research Institute USA (1)
Center for RNA Biology: From Genome to Therapeutics Department of Biochemistry and Biophysics University of Rochester Medical Center Rochester, NY, 14642, USA (1)

Previous page
1 / 1203
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 1203
Next page

Sort by:

Relevance

Page size

DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays

[original title] Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays. The aim of the study was to obtain stable radioresistant sub-lines from the human cervical cancer cell line HeLa by prolonged exposure to 252Cf neu...

ORGANISM(S): Homo sapiens

2010-05-17 | E-GEOD-19526 | biostudies-arrayexpress

Four new coelotine species (Araneae, Agelenidae, Coelotinae) from South China, with the first description of the male of Coelotes septus Wang, Yin, Peng & Xie, 1990.

Not available

S-EPMC8050011 | biostudies-literature

Deep proteomic and phosphoproteomic profiling of DIPG responses to radiation therapy

Different DIPG tumor models have different responses to radiation therapy, which can be identified by quantitative proteomics/phospho-proteomics approach

ORGANISM(S): Homo sapiens (Human)

2024-05-21 | PXD028285 | Pride

Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial.

Not available

S-EPMC10861269 | biostudies-literature

Transcriptomics and metabolomics of engineered Synechococcus elongatus during photomixotrophic growth

BACKGROUND: Converting carbon dioxide (CO2) into value-added chemicals using engineered cyanobacteria is a promising strategy to tackle the global warming and energy shortage issues. However, most cyanobacteria are autotrophic and use CO2 as a sole carbon source, which makes it h...

2022-03-21 | MTBLS2825 | MetaboLights

Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack.

Not available

S-EPMC10446134 | biostudies-literature

Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations.

Not available

S-EPMC12826683 | biostudies-literature

A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Ban-Xia-Xie-Xin-Tang.

Not available

S-EPMC6206573 | biostudies-literature

The motor activity of myosin-X promotes actin fiber convergence at the cell periphery to initiate filopodia formation.

Not available